During the past decade, Glaxo Wellcome Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Glaxo Wellcome Inc" #1 collaborator was "Glaxo Wellcome" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Glaxo Wellcome Inc" are "HIV Infections" (17 trials), "Pneumonia, Pneumocystis Carinii" (2 trials), "AIDS Dementia Complex" (1 trials), "Neuromuscular Diseases" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Glaxo Wellcome Inc" in a lesser frequency.

Most popular intervention types in "Glaxo Wellcome Inc" are "Drug" (17 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (9 trials), "Abacavir sulfate" (3 trials), "Amprenavir" (3 trials), "Atovaquone" (2 trials) and "Didanosine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Glaxo Wellcome Inc" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Glaxo Wellcome Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Glaxo Wellcome Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Glaxo Wellcome Inc, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 16 trials that are defined as “Not Applicable".